Literature DB >> 28064541

The role of IFI35 in lupus nephritis and related mechanisms.

Lihua Zhang1, Honglin Zhu1, Yisha Li1, Xiaodan Dai1, Bin Zhou1, Quanzhen Li2, Xiaoxia Zuo1, Hui Luo1.   

Abstract

OBJECTIVES: It's reported that multiple genes in the IFN-γ/STAT1 pathway were hypomethylated and associated with the pathogenesis of lupus nephritis (LN). Our previous study using microarray analysis suggested that interferon induced 35-kDa protein (IFI35) was hypomethylated and increased in LN. However, the role of IFI35 in LN and related mechanism remains to be elucidate.
METHODS: The expressions of IFNγR, STAT1, IFI35 and MBD2 in the human kidneys tissues was detected by real-time PCR and Western blot. The protein levels of IFI35 in the human kidney tissues were detected by immunohistochemistry. The methylation status of IFNγR, STAT1 and IFI35 were detected by methylation specific PCR. Cell proliferation assay was evaluated using cell counting kit 8; pcDNA-IFI35 (pcDNA-MBD2) or IFI35 RNAi (MBD2 RNAi) was used to upregulated or downregulated the expression of the IFI35 and MBD2.
RESULTS: The expressions of IFNγR, STAT1 and IFI35 in the LN kidneys were significantly higher than controls. IFI35 was expressed in mesangial cells, and positively correlated with the proliferation of mesangial cells. IFNγR, STAT1and IFI35 was hypomethylated and MBD2 was increased in LN kidneys. In vitro data confirmed those findings: after stimulating with the serum from LN patients, the proliferation of human renal mesangial cells (HRMCs) was increased. The expressions of the three members of IFNγ signal pathway were hypomethylated and upregulated. However, this effect was reversed by MBD2 knockdown. IFI35 promoted the proliferation of HRMCs and was regulated by MBD2.
CONCLUSION: Our results demonstrated that IFI35 enhances the proliferation of mesangial cells and was regulated by MBD2 in LN.

Entities:  

Keywords:  Hypomethylation; IFI35; MBD2; Mesangial cells

Mesh:

Substances:

Year:  2017        PMID: 28064541     DOI: 10.1080/14397595.2016.1270387

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  7 in total

Review 1.  Mesangial Cells in Lupus Nephritis.

Authors:  Tamara K Nowling
Journal:  Curr Rheumatol Rep       Date:  2022-01-05       Impact factor: 4.592

2.  Identification of hub biomarkers and immune cell infiltration in polymyositis and dermatomyositis.

Authors:  Si Chen; Haolong Li; Haoting Zhan; Xiaoli Zeng; Hui Yuan; Yongzhe Li
Journal:  Aging (Albany NY)       Date:  2022-05-24       Impact factor: 5.955

3.  The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.

Authors:  Meng Meng; Jieqiong Tan; Weilin Chen; Qian Du; Bin Xie; Nian Wang; Honglin Zhu; Kangkai Wang
Journal:  Front Immunol       Date:  2019-08-20       Impact factor: 7.561

Review 4.  Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage.

Authors:  Chang-Youh Tsai; Chieh-Yu Shen; Chih-Wei Liu; Song-Chou Hsieh; Hsien-Tzung Liao; Ko-Jen Li; Cheng-Shiun Lu; Hui-Ting Lee; Cheng-Sung Lin; Cheng-Han Wu; Yu-Min Kuo; Chia-Li Yu
Journal:  Biomolecules       Date:  2020-12-06

5.  IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy.

Authors:  Dafei Chai; Shang Yuchen Shi; Navid Sobhani; Jiage Ding; Zichun Zhang; Nan Jiang; Gang Wang; Minle Li; Hailong Li; Junnian Zheng; Jin Bai
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

6.  Clinical Values of the Identified Hub Genes in Systemic Lupus Erythematosus.

Authors:  Lu Xiao; Feng Zhan; Shudian Lin
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

7.  IFP35 family proteins promote neuroinflammation and multiple sclerosis.

Authors:  Xizhong Jing; Yongjie Yao; Danning Wu; Hao Hong; Xu Feng; Na Xu; Yingfang Liu; Huanhuan Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-10       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.